Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress
GlobeNewswire
– ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for
Non-Transfusion-Dependent Alpha- and..